Rate of venous thromboembolism in a prospective all-comers cohort with COVID-19
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-742X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Rate of venous thromboembolism in a prospective all-comers cohort with COVID-19 ; day:2 ; month:7 ; year:2020 ; pages:1-9
Journal of thrombosis and thrombolysis ; (2.7.2020), 1-9
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11239-020-02202-8
- URN
-
urn:nbn:de:101:1-2020090123080190793035
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rieder, Marina
- Goller, Isabella
- Jeserich, Maren
- Baldus, Niklas
- Pollmeier, Luisa
- Wirth, Luisa
- Supady, Alexander
- Bode, Christoph
- Busch, Hans-Jörg
- Schmid, Bonaventura
- Dürschmied, Daniel
- Gauchel, Nadine
- Lother, Achim
- SpringerLink (Online service)
Ähnliche Objekte (12)
Procedural justice and egalitarian principles for rationing decisions in the COVID-19 crisis
Extracorporeal cytokine adsorption as an alternative to pharmacological inhibition of IL-6 in COVID-19
A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): a structured summary of a study protocol for a randomised controlled trial
A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial
Rate of venous thromboembolism in a prospective all-comers cohort with COVID-19
The effects of serotonin in immune cells
Platelet contributions to myocardial ischemia/reperfusion injury
Cytokine adsorption in critically Ill patients requiring ECMO support
Use of the CytoSorb adsorption device in MDMA intoxication: a first-in-man application and in vitro study
Outcome prediction in patients with severe COVID-19 requiring extracorporeal membrane oxygenation - a retrospective international multicenter study
Serotonin: a platelet hormone modulating cardiovascular disease
Platelets in Myocardial Ischemia/Reperfusion Injury
Procedural justice and egalitarian principles for rationing decisions in the COVID-19 crisis
Extracorporeal cytokine adsorption as an alternative to pharmacological inhibition of IL-6 in COVID-19
A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): a structured summary of a study protocol for a randomised controlled trial
A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial
Rate of venous thromboembolism in a prospective all-comers cohort with COVID-19
The effects of serotonin in immune cells
Platelet contributions to myocardial ischemia/reperfusion injury
Cytokine adsorption in critically Ill patients requiring ECMO support
Use of the CytoSorb adsorption device in MDMA intoxication: a first-in-man application and in vitro study
Outcome prediction in patients with severe COVID-19 requiring extracorporeal membrane oxygenation - a retrospective international multicenter study
Serotonin: a platelet hormone modulating cardiovascular disease
Platelets in Myocardial Ischemia/Reperfusion Injury
Procedural justice and egalitarian principles for rationing decisions in the COVID-19 crisis
Extracorporeal cytokine adsorption as an alternative to pharmacological inhibition of IL-6 in COVID-19
A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): a structured summary of a study protocol for a randomised controlled trial
A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial
Rate of venous thromboembolism in a prospective all-comers cohort with COVID-19
The effects of serotonin in immune cells
Platelet contributions to myocardial ischemia/reperfusion injury
Cytokine adsorption in critically Ill patients requiring ECMO support
Use of the CytoSorb adsorption device in MDMA intoxication: a first-in-man application and in vitro study
Outcome prediction in patients with severe COVID-19 requiring extracorporeal membrane oxygenation - a retrospective international multicenter study
Serotonin: a platelet hormone modulating cardiovascular disease